Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1/2 6Phase 1 6Phase 4 2Phase 3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 1905Neoplasms 1528Prostatic Neoplasms 751Colorectal Neoplasms 714Lung Neoplasms 582Motor Activity 391Head and Neck Neoplasms 328Colonic Neoplasms 311Uterine Cervical Neoplasms 297Pain 247Pancreatic Neoplasms 246Anxiety Disorders 220Rectal Neoplasms 213Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 193Stomach Neoplasms 191Polycystic Ovary Syndrome 188Ovarian Neoplasms 185Precursor Cell Lymphoblastic Leukemia-Lymphoma 177Brain Neoplasms 168Urinary Bladder Neoplasms 165Depression 164Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 137Lymphoma 135Lymphoma, Follicular 128Obesity 127

Interventions

Risk Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Completed × Neoplasms, Squamous Cell × Clear all
NCT03509467 2025-12-19

Using MC1R Genotype to Impact Melanoma Risk Behavior

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
2,054 enrolled 92 charts
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasms, Neoplasms, Basal Cell, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡